IQ Consortium News
2019 NewsBack to News
December 6, 2019
IQ DILI is pleased to announce their latest publication in AP&T on detection, assessment and management best practices for suspected DILI in clinical trials for adults with cholestatic liver disease.
November 8, 2019
The IQ MPS Affiliate has launched its new website. Open this story to learn more about the Affiliate and its activities.
October 23, 2019
Congratulations to the 2019 Global 3Rs Award Winners!
October 15, 2019
IQ Clinical Pharmacology, and Translational and ADME Sciences Leadership Groups participate in significant scientific exchange at US FDA OCP.
October 7, 2019
Join IQ as it celebrates the tremendous efforts of the 2019 IQ Recognition Award recipients.
September 30, 2019
IQ Consortium Clinical Pharmacology Leadership Group Meets with the Japan Pharmaceutical Manufacturers Association (JPMA) and the Pharmaceuticals and Medical Devices Agency (PDMA)
August 9, 2019
IQ DILI collaborated with Biorepository, nationwide DILI experts in industry, academia, and US FDA to develop comprehensive guidelines addressing best practices for bio specimen collection.
April 15, 2019
IQ Consortium Analytical Leadership Group's Dissolution Working Group Starts Public Webinar Series
February 27, 2019
IQ has released a series of case studies on high-impact initiatives led by IQ working groups.
January 24, 2019
The assessment tools for partner research organization animal care and use programs were developed with IQ member company and CRO input.
January 24, 2019
IQ was involved in a recent USP Workshop, Enhanced Approaches for Analytical Procedure Lifecycle.